Niu Xiaoying, Tian Wen, Ke Yuanmeng, Li Yifan, Zhang Xinxin
The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
The School of Public Health, Zhengzhou University, Henan, 450001, China.
Cancer Cell Int. 2025 Aug 19;25(1):308. doi: 10.1186/s12935-025-03930-8.
Osteosarcoma is one of the malignant tumors in children and adolescents patients. Uncontrolled and unlimited proliferation and metastasis lead to poor overall survival. CAFs play a pivotal role in the osteosarcoma tumor microenvironment, exerting significant influence on prognosis and treatment outcomes. However, there remains a need for further exploration into the intricate molecular mechanisms underlying CAFs.
Single-cell RNA sequencing was employed to characterize the microenvironment of osteosarcoma. Tissue exosomal miRNA sequencing was conducted on tumor tissues and adjacent normal tissues to screen for abnormal expression of exosomal miRNAs. WGCNA analysis was used to identify target exosomal miRNAs. The relative expression of miR-21-5p was analyzed using qRT-PCR. The proliferation rate and migration ability of tumor cells were assessed using the CCK8 and Transwell method, respectively. Exosomes derived from cells were extracted and characterized via transmission electron microscopy and NTA analysis. siRNA interference was utilized to disrupt the expression of miR-21-5p in CAFs. Experiments in vivo validated the role of exosomal miR-21-5p in promoting malignant characteristics in osteosarcoma.
Single-cell RNA sequencing analysis of GSE162454 revealed the crucial role of CAFs in the pathogenesis of osteosarcoma. Tissue exosomal miRNA sequencing unveiled significant differential expression of miR-21-5p. Subsequently, aberrant upregulation of exosomal miR-21-5p exhibited a strong correlation with advanced clinical stage and poor prognosis in osteosarcoma. Further experiments in vitro indicated that elevated levels of miR-21-5p significantly enhanced proliferation and migration of osteosarcoma cells by suppressing ferroptosis. Moreover, experiments in vivo validated the capacity of CAFs-derived exosomal miR-21-5p to promote tumor growth and weight, thereby demonstrating their ability to deliver miR-21-5p to osteosarcoma cells and induce proliferation and migration through inhibition of ferroptosis.
Our findings indicate that exosomal miR-21-5p could potentially serve as a therapeutic target in osteosarcoma, providing initial evidence for further clinical investigation.
骨肉瘤是儿童和青少年患者中的恶性肿瘤之一。不受控制的无限增殖和转移导致总体生存率低下。癌相关成纤维细胞(CAFs)在骨肉瘤肿瘤微环境中起关键作用,对预后和治疗结果有重大影响。然而,仍需要进一步探索CAFs背后复杂的分子机制。
采用单细胞RNA测序来表征骨肉瘤的微环境。对肿瘤组织和相邻正常组织进行组织外泌体miRNA测序,以筛选外泌体miRNA的异常表达。利用加权基因共表达网络分析(WGCNA)来鉴定靶向外泌体miRNA。使用qRT-PCR分析miR-21-5p的相对表达。分别使用CCK8和Transwell方法评估肿瘤细胞的增殖率和迁移能力。通过透射电子显微镜和纳米颗粒跟踪分析(NTA)对细胞来源的外泌体进行提取和表征。利用小干扰RNA(siRNA)干扰来破坏CAFs中miR-21-5p的表达。体内实验验证了外泌体miR-21-5p在促进骨肉瘤恶性特征方面的作用。
对GSE162454进行单细胞RNA测序分析揭示了CAFs在骨肉瘤发病机制中的关键作用。组织外泌体miRNA测序揭示了miR-21-5p的显著差异表达。随后,外泌体miR-21-5p的异常上调与骨肉瘤的晚期临床分期和不良预后密切相关。进一步的体外实验表明,miR-21-5p水平升高通过抑制铁死亡显著增强了骨肉瘤细胞的增殖和迁移。此外,体内实验验证了CAFs来源的外泌体miR-21-5p促进肿瘤生长和重量增加的能力,从而证明它们能够将miR-21-5p传递给骨肉瘤细胞并通过抑制铁死亡诱导增殖和迁移。
我们的研究结果表明,外泌体miR-21-5p可能是骨肉瘤的一个治疗靶点,为进一步的临床研究提供了初步证据。